Searchable abstracts of presentations at key conferences in endocrinology

ea0015p169 | Endocrine tumours and neoplasia | SFEBES2008

Menin-mutation negative MEN1-syndrome patients have no germline p27 (cyclin-dependent kinase inhibitor 1B) or AIP (aryl hydrocarbon receptor-interacting protein) mutations

Igreja Susana , Chahal Harvinder , Akker Scott , Gueorguiev Maria , Popovic Vera , Wass John , Grossman Ashley , Korbonits Marta

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant negative disorder characterised by the occurrence of multiple adenomas including hyperplasia and/or neoplasm of the parathyroid glands, pancreatic islets and pituitary glands. Germline mutations in the menin gene predispose to the MEN1 syndrome; however, about 10–20% of patients with MEN1 do not have a detectable menin mutation. Recently, a mouse strain with a MEN1-like phenotype has been re...

ea0021p210 | Endocrine tumours and neoplasia | SFEBES2009

Functional characterisation of aryl hydrocarbon receptor interacting protein (AIP) promoter and silent mutations

Igreja Susana , Chahal Harvinder , King Peter , Bolger Graeme , Srirangalingam Umasuthan , Guasti Leonardo , Chappel Paul , Gueorguiev Maria , Guegan Katie , Stals Karen , Khoo Bernard , Kumar Ajith , Ellard Sian , Grossman Ashley B , Korbonits Marta

AIP mutations predispose to familial isolated pituitary adenomas (FIPA) and 45 different AIP mutations have been described in the literature. Most of these mutations result in complete disruption of the C-terminal region of the AIP protein due to early stop codons. In this study we were particularly interested in the effect of AIP mutations in the promoter region (−270−−269CG & −220C) and 2 synonymous mutations (c.249G>T, p.G83= and c...

ea0015p192 | Endocrine tumours and neoplasia | SFEBES2008

AIP: a protein mutated in familial acromegaly plays a role in the regulation of cell proliferation and shows cell-type specific subcellular localisation

Leontiou Chrysanthia A , Gueorguiev Maria , Hassan Sevda , van der Spuy Jacqueline , Lolli Francesca , Stolbrink Maria , Christian Helen , Wray Jennifer , Bishop-Bailey David , Berney Dan M , Frohman Lawrence A , Chapple Paul J , Grossman Ashley B , Korbonits Marta

Mutations in AIP have been identified in a significant proportion of families with pituitary adenomas, most commonly in familial acromegaly. However, no data are available about the pituitary expression of AIP and how lack of AIP is involved in tumorigenesis.We identified 10 kindreds with AIP mutations out of 31 families. We studied RNA and protein expression of AIP in normal as well as familial and sporadic pituitary adenomas. In the normal pituitary st...

ea0013p252 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

AIP and familial acromegaly

Gueorguiev Maria , Lolli Francesca , Leontiou Chrysanthia , Chapple Paul , Quinton Richard , Ribeiro-de-Oliveira Antonio , Gadelha Monica , Popovic Vera , Monson John , Wass John , Frohman Lawrence , Grossman Ashley , Korbonits Márta

Acromegaly is almost always due to a sporadic growth-hormone secreting pituitary adenoma, but familial acromegaly has been reported occasionally. Linkage and loss of heterozygosity studies have suggested that it is caused by a tumour suppressor gene located at 11q13. Recently mutations have been identified in a gene in some families with acromegaly alone or acromegaly and prolactinoma. The gene codes for the aryl hydrocarbon receptor interactive protein (AIP), a molecular chap...